Summit Therapeutics Inc (SMMT)
8.39
+0.30
(+3.71%)
USD |
NASDAQ |
Jun 14, 16:00
8.38
-0.01
(-0.12%)
After-Hours: 20:00
Summit Therapeutics Cash from Operations (TTM): -93.76M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -93.76M |
December 31, 2023 | -76.76M |
September 30, 2023 | -52.11M |
June 30, 2023 | -45.77M |
March 31, 2023 | -35.71M |
December 31, 2022 | -41.58M |
September 30, 2022 | -55.95M |
June 30, 2022 | -70.96M |
March 31, 2022 | -70.92M |
December 31, 2021 | -72.59M |
September 30, 2021 | -71.38M |
June 30, 2021 | -64.46M |
March 31, 2021 | -63.82M |
December 31, 2020 | -48.11M |
September 30, 2020 | -48.75M |
June 30, 2020 | -42.33M |
March 31, 2020 | -22.00M |
October 31, 2019 | -24.02M |
July 31, 2019 | -20.10M |
Date | Value |
---|---|
April 30, 2019 | -23.72M |
January 31, 2019 | -35.11M |
October 31, 2018 | -36.96M |
July 31, 2018 | -46.05M |
April 30, 2018 | -19.88M |
January 31, 2018 | -20.58M |
October 31, 2017 | -18.47M |
July 31, 2017 | 29.72M |
April 30, 2017 | 14.20M |
January 31, 2017 | 15.18M |
October 31, 2016 | 14.67M |
July 31, 2016 | -26.13M |
April 30, 2016 | -27.82M |
January 31, 2016 | -24.47M |
October 31, 2015 | -21.71M |
July 31, 2015 | -18.48M |
April 30, 2015 | -20.13M |
January 31, 2015 | -16.59M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-93.76M
Minimum
Mar 2024
-20.10M
Maximum
Jul 2019
-53.74M
Average
-52.11M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
Merck & Co Inc | 14.76B |
Eli Lilly and Co | 3.676B |
Novo Integrated Sciences Inc | -4.952M |
Insmed Inc | -573.98M |
Retractable Technologies Inc | 4.444M |